Entrada Therapeutics, Inc. (NASDAQ:TRDA) appears in 109 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 5,072,730 | 0 | 0.00% | $64,017,853.00 |
| 5AM Venture Management, LLC | 31 Mar, 2026 | 4,056,379 | 0 | 0.00% | $51,191,503.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 2,358,793 | 211,533 | 9.85% | $29,767,968.00 |
| TCG Crossover Management, LLC | 31 Mar, 2026 | 2,287,500 | 199,108 | 9.53% | $28,868,250.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,256,013 | 1,256,013 | 0.00% | $15,850,884.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 1,034,782 | -9,976 | -0.95% | $13,058,949.00 |
| StepStone Group LP | 31 Mar, 2026 | 761,277 | 0 | 0.00% | $9,607,316.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 667,347 | 27,400 | 4.28% | $8,423,655.00 |
| State Street Corp | 31 Mar, 2026 | 533,798 | 25,009 | 4.92% | $6,736,531.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 526,043 | 526,043 | 0.00% | $6,639.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 519,356 | 21,661 | 4.35% | $6,554,273.00 |
| Jones Hill Capital LP | 31 Mar, 2026 | 374,010 | 374,010 | 0.00% | $4,720,006.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31 Mar, 2026 | 333,914 | -28,872 | -7.96% | $4,213,995.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Mar, 2026 | 333,169 | 22,336 | 7.19% | $4,201.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 324,471 | 51,093 | 18.69% | $4,091,871.00 |
| Northern Trust Corp | 31 Mar, 2026 | 234,992 | 8,691 | 3.84% | $2,965,599.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 220,494 | 220,494 | 0.00% | $2,782,634.00 |
| Woodline Partners LP | 31 Mar, 2026 | 215,977 | 73,867 | 51.98% | $2,725,630.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 215,018 | -77,752 | -26.56% | $2,713,527.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Mar, 2026 | 214,751 | -6,518 | -2.95% | $2,710,158.00 |